Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.

2008

Objective: RBx 7796, a 5-lipoxygenase inhibitor, was evaluated in in vivo efficacy models, in vitro ADME and in vivo pharmacokinetic models.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

31

References

5

Citations